REVIEW

Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas

N J Sebire, M Malone

Department of Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London GU21 2FB, UK

Correspondence to:
Correspondence to:
Dr N J Sebire, Department of Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London GU21 2FB, UK;
njsebire{at}hotmail.com

The diagnosis of paediatric solid tumours is often based on small tissue needle biopsies in which many different entities demonstrate a "small round cell tumour" phenotype and in which there may be insufficient tissue to allow the interpretation of diagnostic architectural features, which may be present in larger specimens. Therefore, the extensive use of a panel of immunohistochemical markers is part of the routine handling and investigation of such biopsies to reach a definite diagnosis. However, in some cases the morphological and routine immunohistochemical findings may be insufficient for a precise diagnosis or they may be difficult to interpret in the given clinical context. Although many paediatric tumours exhibit characteristic chromosomal translocations with resultant specific fusion transcripts, these require molecular methods for their detection, usually on fresh tissue samples, which may not always be available. As more immunohistochemical markers become available, more precise diagnosis on such small biopsies may be possible. This review examines the use of the immunohistochemical markers, MyoD1 and myogenin, in the diagnosis of paediatric rhabdomyosarcoma, including its subtypes.

Keywords: alveolar; embryonal; MyoD1; myogenin; rhabdomyosarcoma

Abbreviations: ARMS, alveolar rhabdomyosarcoma; ERMS, embryonal rhabdomyosarcoma; RMS, rhabdomyosarcoma; RT-PCR, reverse transcriptase polymerase chain reaction

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Nanni, P., Nicoletti, G., Palladini, A., Astolfi, A., Rinella, P., Croci, S., Landuzzi, L., Monduzzi, G., Stivani, V., Antognoli, A., Murgo, A., Ianzano, M., De Giovanni, C., Lollini, P.-L. (2009). Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. Molecular Cancer Therapeutics 8: 754-761 [Abstract] [Full Text]  
• Barr, F. G., Meyer, W. H. (2008). Rhabdomyosarcoma: An Overview of Biology, Clinical Features, and the Current Children's Oncology Group Studies. Am Soc Clin Oncol Ed Book 2008: 465-470 [Abstract] [Full Text]  
• Breitfeld, P. P., Meyer, W. H. (2005). Rhabdomyosarcoma: New Windows of Opportunity. The Oncologist 10: 518-527 [Abstract] [Full Text]